Trexquant Investment’s iShares Biotechnology ETF IBB Stock Holding History

Trexquant Investment’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,412	Closed	-$468K	–	1668
2024 Q1	$468K	Buy	+3,412	New	+$466K	0.01%	1169
2023 Q4	–	Sell	-6,540	Closed	-$800K	–	1584
2023 Q3	$800K	Buy	6,540 +446	+7%	+$56.7K	0.02%	837
2023 Q2	$774K	Buy	+6,094	New	+$792K	0.02%	842
2022 Q4	–	Sell	-3,418	Closed	-$400K	–	1532
2022 Q3	$400K	Buy	3,418 +1,189	+53%	+$148K	0.01%	905
2022 Q2	$262K	Buy	+2,229	New	+$265K	0.01%	1194
2021 Q4	–	Sell	-3,749	Closed	-$606K	–	1434
2021 Q3	$606K	Buy	+3,749	New	+$631K	0.05%	459
2021 Q2	–	Sell	-2,858	Closed	-$430K	–	1275
2021 Q1	$430K	Buy	+2,858	New	+$454K	0.04%	579
2020 Q2	–	Sell	-21,552	Closed	-$2.32M	–	1281
2020 Q1	$2.32M	Buy	+21,552	New	+$2.48M	0.17%	174

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Trexquant Investment's IBB Position: Q2 2024 in Review

Trexquant Investment sold out of iShares Biotechnology ETF (IBB) in Q2 2024, closing a stake of 3,412 shares — an estimated $468K sold.

Trexquant Investment first reported a position in IBB in Q1 2020 and held it in 8 quarters. The position peaked at $2.32M in Q1 2020. 894 funds tracked by Wall St. Rank hold IBB as of Q2 2024.

Trexquant Investment reported no remaining iShares Biotechnology ETF position as of Q2 2024 after selling out during the quarter.
Trexquant Investment sold 3,412 iShares Biotechnology ETF shares in Q2 2024, an estimated $468K.
Trexquant Investment first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 8 quarters.
Trexquant Investment's iShares Biotechnology ETF position peaked at $2.32M in Q1 2020.
894 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2024.

Based on Trexquant Investment's 13F filing for Q2 2024, filed 13 Aug 2024.